Trial intelligence / Profile preview

Comparison of levobupivacaine, ropivacaine, and bupivacaine for combined psoas compartment-sciatic nerve block in total hip replacement

NL-OMON27060Active, not recruiting

Sponsor
Amsterdam UMC, location VUmc
Start
Jun 2003
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Levobupivacaine PCSNB, Ropivacaine PCSNB and Bupivacaine + epinephrine PCSNB (3 arms). Primary endpoint: Pain intensity at rest at 48 hours. Started Jun 2003; status: active, not recruiting.

02

Drugs

levobupivacaineropivacainebupivacaineepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NL-OMON27060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call